EP Patent

EP4604942A1 — Content uniformity of teriflunomid in pharmaceutical dosage forms

Assigned to Ilko Ilac Sanayi ve Ticaret AS · Expires 2025-08-27 · 1y expired

What this patent protects

The invention relates to develop a pharmaceutical tablet composition for oral administration, comprising Teriflunomide or а pharmaceutically ассерtаblе salt thereof, and а method for the preparation of said tablet with obtaining teriflunomide containing granules using wet granula…

USPTO Abstract

The invention relates to develop a pharmaceutical tablet composition for oral administration, comprising Teriflunomide or а pharmaceutically ассерtаblе salt thereof, and а method for the preparation of said tablet with obtaining teriflunomide containing granules using wet granulation method and using a specific particle size distribution of Teriflunomide granules to provide content uniformity of tablets.

Drugs covered by this patent

Patent Metadata

Patent number
EP4604942A1
Jurisdiction
EP
Classification
Expires
2025-08-27
Drug substance claim
No
Drug product claim
No
Assignee
Ilko Ilac Sanayi ve Ticaret AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.